2257 - Patient-Based Dosimetric Analysis of Photon GRID SFRT: Insights from a Large Institutional Experience
Presenter(s)
K. Wang1, P. Sabouri2, R. Hou3, R. J. Griffin4, and F. Xia2; 1Department of Radiation Oncology, UAMS Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 2Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, 3University of Arkansas for Medical Sciences, LITTLE ROCK, AR, 4University of Arkansas for Medical Sciences, Little Rock, AR
Purpose/Objective(s):
In an effort to standardize photon GRID radiation therapy (GRID RT) prescription and planning, the Radiosurgery Society (RSS) published a consensus guideline (Zhang et al., 2020) outlining several key dosimetric parameters. Since then, studies have been published reporting dosimetric characters based on phantom-generated data. Our study, however, is one of the first and largest reports based on actual patient-generated data from a single institute.Materials/Methods:
Dosimetric plans for 44 patients treated with GRID RT at our institution were retrospectively analyzed. Dose metrics recommended by the RSS GRID/LATTICE working group were extracted and evaluated. Key dose metrics, including peak-to-valley ratio (P/V), peak-to-peak distance (p-p), and peak width (defined by full width half maximum) were assessed at Dmax, 50% and 90% of maximal depth for each treatment energy. Additionally, global metrics such as target size, maximum depth and D10%/D90% are reported.Results:
Of the 44 patients considered, 9 received 6MV-FFF, 34 received 10MV-FFF, and one received 18MV. Target depths increased with energy: 7.6 ± 2.4 cm (6MV), 10.8 ± 3.0 cm (10MV), and 17.8 cm (18MV). Average target doses (D50%) ranged from 7–10 Gy, increasing with energy: 732 ± 134 cGy (6MV), 755 ± 94 cGy (10MV), and 1022 cGy (18MV). The D10(%)/D90(%) ratio decreased with energy due to greater lateral penumbra, leading to lower valley doses. The highest values were observed for 6 MV (5.5 ± 1.0), decreasing for 10MV (3.6 ± 1.3) and 18MV (3.2). The peak dose and P/V ratio declined with depth due to beam lateral scatter. For 6MV, P/V dropped from 7.8 ± 1.6 at Dmax to 5.7 ± 1.3 at mid-target and 5.0 ± 1.2 at the distal edge. A similar trend was observed for 10MV from 3.7 ± 0.4 at Dmax to 3.4 ± 0.6 at mid-target and 3.0 ± 0.3 at the distal target edge and for 18MV(2.8 to 2.1). Peak width exhibited a minor increase with depth (~2–3 mm) due to beam divergence, ranging from ~1.0 cm (6MV) to ~1.3 cm (18MV). Similarly, p-p distance increased slightly (1–2 mm) at 1.46-1.58 cm (6MV), 1.36-1.44 cm (10MV) and 1.8-2.1 cm (18MV) depths.Conclusion: Our study provides the first patient-based dosimetric analysis of photon GRID RT at our institution, which is valuable for pre-clinical modeling and future clinical planning. The data reveals valuable insights for treatment parameters across different beam energies and for the ongoing refinement of GRID RT prescription and planning
Table 1| Energy (MV) | Target Maximum Depth (cm) | Volume (cm3) | D50% (cGy) | D10(%)/D90(%) | Measured Depth (cm) | Peak to Valley | Peak Width (cm) | Peak-to-peak Distance (cm) |
| 6 | 7.6 ± 2.4 | 205± 159 | 732 ± 134 | 5.5 ± 1.0 | Dmax: 1.17 ± 0.09 | 7.8 ± 1.6 | 0.93 ± 0.10 | 1.46 ± 0.31 |
| mid: 3.82 ± 1.18 | 5.7 ± 1.3 | 0.94 ± 0.13 | 1.53 ± 0.37 | |||||
| distal: 6.88 ± 2.13 | 5.0 ± 1.2 | 1.01 ± 0.10 | 1.58 ± 0.35 | |||||
| 10 | 10.8 ± 3.0 | 450 ± 397 | 755 ± 94 | 3.6 ± 1.3 | Dmax: 1.94 ± 0.39 | 3.7 ± 0.4 | 0.95 ± 0.09 | 1.36 ± 0.26 |
| mid: 5.41 ± 1.48 | 3.4 ± 0.6 | 1.02 ± 0.11 | 1.41 ± 0.24 | |||||
| distal: 9.74 ± 2.67 | 3.0 ± 0.3 | 1.06 ± 0.11 | 1.44 ± 0.24 | |||||
| 18 | 17.8 | 932 | 1022 | 3.2 | Dmax: 3.82 | 2.8 | 1.20 | 1.81 |
| mid: 8.90 | 2.3 | 1.32 | 1.95 | |||||
| distal: 16.02 | 2.1 | 1.53 | 2.08 |